2022 Annual Meeting | C109 - Chronic Traumatic Encephalopathy

Date Tuesday 04/05/22

Time 03:30 PM - 05:30 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Andrew E. Budson, MD

Topic(s) Aging, Dementia, and Behavioral Neurology

Learning Objectives Upon completion participants will learn the pathology that defines CTE; understand the interaction between CTE pathology and repetitive head impacts; discover the many secondary pathologies that are often present with CTE pathology; describe the MRI, PET, CSF, and plasma biomarkers that may allow detection of CTE during life; classify patients with possible CTE using the 2021 diagnostic criteria; diagnose & treat patients with possible CTE in clinical practice.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Advanced

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider

Teaching Styles Didactic

Program Materials Program Evaluations

Event Timeline
03:30 PM - 04:10 PM PDT	Speaker	Neuropathology of Chronic Traumatic Encephalopathy and the Role of Repetitive Head Impacts in Multiple Neurodegenerations Thor D. Stein, MD, PhD
03:30 PM - 03:30 PM PDT	Speaker	Walk-in Slides Andrew E. Budson, MD
04:10 PM - 04:50 PM PDT	Speaker	Can We Detect Chronic Traumatic Encephalopathy During Life Yet? Updates on Imaging and Fluid Biomarkers Michael Alosco, PhD
04:50 PM - 05:30 PM PDT	Speaker	Diagnosis and Treatment of Individuals with Possible CTE: What Clinicians Can Do Today Andrew E. Budson, MD

Faculty Disclosures
Andrew E. Budson, MD	Dr. Budson has received personal compensation for serving as an employee of Boston Center for Memory. Dr. Budson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Budson has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eli Lilly. The institution of Dr. Budson has received research support from Department of Veterans Affairs. The institution of Dr. Budson has received research support from NIH. The institution of Dr. Budson has received research support from Bristol Myers Squibb. The institution of Dr. Budson has received research support from VoxNeuro. Dr. Budson has received publishing royalties from a publication relating to health care. Dr. Budson has received publishing royalties from a publication relating to health care. Dr. Budson has a non-compensated relationship as a Alzheimer's Advisory Panel with Commonwealth of Massachusetts that is relevant to AAN interests or activities.
Michael Alosco, PhD	The institution of Michael Alosco, PhD has received research support from NIH. The institution of Michael Alosco, PhD has received research support from Life Molecular Imaging Inc.
Thor D. Stein, MD, PhD	Dr. Stein has nothing to disclose.

��ɫ��

��ɫ��